Skip to main content
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
131.62
+2.73 (2.12%)
At close: Aug 13, 2025, 4:00 PM
134.51
+2.89 (2.20%)
After-hours: Aug 13, 2025, 6:56 PM EDT

Neurocrine Biosciences Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Ingrezza
2.40B 2.35B 2.31B 2.20B 2.07B 1.93B 1.84B 1.74B - -
Ingrezza Growth
15.74% 21.80% 26.00% 26.72% 27.42% 25.79% 28.59% 30.49% - -
Collaboration and Other
26.40M 27.30M 24.70M 26.20M 27.70M 27.70M 26.50M 25.90M
Collaboration and Other Growth
-4.69% -1.44% -6.79% 1.16% 0.73% -41.44% -44.56% -47.03%
Ongentys and Other Products
18.30M 18.20M 17.20M 18.00M 20.40M 22.70M 24.60M 23.00M - - -
Ongentys and Other Products Growth
-10.29% -19.82% -30.08% -21.74% 3.03% 45.51% 87.79% 125.49% - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.